KR20220156274A - Cosmetic composition comprising natural herb complex extract as effective component - Google Patents

Cosmetic composition comprising natural herb complex extract as effective component Download PDF

Info

Publication number
KR20220156274A
KR20220156274A KR1020210064099A KR20210064099A KR20220156274A KR 20220156274 A KR20220156274 A KR 20220156274A KR 1020210064099 A KR1020210064099 A KR 1020210064099A KR 20210064099 A KR20210064099 A KR 20210064099A KR 20220156274 A KR20220156274 A KR 20220156274A
Authority
KR
South Korea
Prior art keywords
cosmetic composition
skin
extract
asparagus
effect
Prior art date
Application number
KR1020210064099A
Other languages
Korean (ko)
Other versions
KR102525630B1 (en
Inventor
오세민
Original Assignee
(주)뷰리클
오세민
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)뷰리클, 오세민 filed Critical (주)뷰리클
Priority to KR1020210064099A priority Critical patent/KR102525630B1/en
Publication of KR20220156274A publication Critical patent/KR20220156274A/en
Application granted granted Critical
Publication of KR102525630B1 publication Critical patent/KR102525630B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a cosmetic composition comprising a natural herb complex extract as an active ingredient, and more specifically, to a cosmetic composition which comprises a complex extract of Terminalia ferdinandiana, Phyllanthus emblica fruits, watercress, asparagus and pea as an active ingredient, and which exhibits excellent skin protection effect, skin inflammation alleviation effect, skin irritation relief and soothing effect, and skin barrier strengthening effect.

Description

천연 복합추출물을 유효성분으로 함유하는 화장료 조성물{Cosmetic composition comprising natural herb complex extract as effective component}Cosmetic composition comprising natural herb complex extract as an effective component

본 발명은 천연 복합추출물을 유효성분으로 함유하는 화장료 조성물에 관한 것으로, 구체적으로는 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩 복합추출물을 유효성분으로 함유하여 우수한 피부 재생 효과, 피부 염증개선 효과, 피부 자극완화 및 진정효과 및 피부 장벽강화 효과를 나타내는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing a natural complex extract as an active ingredient, and specifically, it contains kakadu plum, Indian gooseberry, watercress, asparagus and pea complex extracts as active ingredients for excellent skin regeneration effect and skin inflammation improvement It relates to a cosmetic composition exhibiting effects, skin irritation relief and soothing effects, and skin barrier strengthening effects.

피부의 최외각층인 표피층은 각질형성세포로 구성되어 있으며 화학물질, 대기오염물질, 건조한 환경, 자외선 등의 외부 다양한 자극으로부터 피부를 보호하는 역할을 한다. 그 중에서도 표피층 가장 바깥에 존재하는 각질층은 각질형성세포에 의해 형성되어 각질형성 세포와 지질층으로 구성되어 있다. The epidermal layer, the outermost layer of the skin, is composed of keratinocytes and serves to protect the skin from various external stimuli such as chemicals, air pollutants, dry environments, and ultraviolet rays. Among them, the outermost stratum corneum of the epidermal layer is formed by keratinocytes and is composed of keratinocytes and a lipid layer.

각질 세포는 일정한 주기에 따라 탈락과 새로운 각질세포가 생성되며과도한 물리적 자극, 화학적 자극, 온도변화 등의 환경적인 자극에 따라 그 기능이 쉽게 손상될 수 있다. 또한 현대사회의 환경오염으로 인한 미세먼지, 황사, 큰 일교차 등은 각질층에 극심한 스트레스를 유발할 수 있어 표피층, 구체적으로는 각질층을 외부자극으로부터 보호하고 진정 시킬 수 있는 피부 장벽강화용 화장료 개발이 필요하다.Keratinocytes are exfoliated and new keratinocytes are generated according to a certain cycle, and their functions can be easily damaged by environmental stimuli such as excessive physical stimulation, chemical stimulation, and temperature change. In addition, fine dust, yellow dust, and large diurnal temperature differences caused by environmental pollution in modern society can cause extreme stress on the stratum corneum, so it is necessary to develop cosmetics for strengthening the skin barrier that can protect and soothe the epidermal layer, specifically the stratum corneum, from external stimuli. .

본 발명자들은 피부염증 개선, 피부 보호 및 피부장벽 강화 활성을 가지는 천연물에 대한 연구를 하던 중 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스, 완두콩 등이 이러한 활성을 나타내는 것을 확인하였다. The present inventors confirmed that kakadu plum, Indian gooseberry, watercress, asparagus, peas, etc. exhibit these activities while studying natural products having skin inflammation improvement, skin protection and skin barrier strengthening activities.

종래, 효소 처리된 카카두 플럼 추출물이 항산화, 항염 효과 등을 가지고 있고, 암라(인디언구스베리) 추출물이 탈모 및 발모촉진에 효과가 있다는 것이 개시되어 있다. 또한, 초음파 기술을 이용한 물냉이 추출물의 피부 재생 및 항산화 효과나, 아스파라거스 줄기 혼합추출물의 항염증 효과, 완두콩 혼합추출물의 피부 손상개선효과에 대한 것이 알려져 있다(하기 선행기술 문헌 1-5). 그러나 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩 복합추출물의 피부 개선활성에 대한 선행 연구는 아직까지 이루어지지 않았다.Conventionally, it has been disclosed that an enzyme-treated kakadu plum extract has antioxidant and anti-inflammatory effects, and an Amla (Indian gooseberry) extract is effective for hair loss and hair growth promotion. In addition, it is known about the skin regeneration and antioxidant effects of watercress extract using ultrasonic technology, the anti-inflammatory effect of asparagus stem mixture extract, and the skin damage improvement effect of pea mixture extract (Prior Art Documents 1-5 below). However, prior research on the skin improvement activity of kakadu plum, Indian gooseberry, watercress, asparagus and pea complex extracts has not been done yet.

본 발명자들은 특정한 방법에 의하여 제조되는 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩 복합추출물이 그 상승효과에 의하여 우수한 피부 재생효과, 피부 염증개선 효과, 피부 자극완화 및 진정효과, 피부 장벽강화 효과를 나타낸다는 것을 확인하여 본 발명을 완성하였다.The present inventors found that the kakadu plum, Indian gooseberry, watercress, asparagus, and pea complex extracts prepared by a specific method have excellent skin regeneration effects, skin inflammation improvement effects, skin irritation relief and soothing effects, and skin barrier strengthening due to their synergistic effects. The present invention was completed by confirming that the effect is shown.

(001) 대한민국 등록특허 제10-1965250호(2019.03.28)(001) Republic of Korea Patent Registration No. 10-1965250 (2019.03.28) (002) 대한민국 공개특허 제10-2018-0013422호(2018.02.07)(002) Republic of Korea Patent Publication No. 10-2018-0013422 (2018.02.07) (003) 대한민국 등록특허 제10-2062010호(2019.12.26)(003) Republic of Korea Patent No. 10-2062010 (2019.12.26) (004) 대한민국 공개특허 제10-2018-0082177호(2018.07.18)(004) Republic of Korea Patent Publication No. 10-2018-0082177 (2018.07.18) (005) 대한민국 등록특허 제10-1829553호(2018.02.08)(005) Republic of Korea Patent Registration No. 10-1829553 (2018.02.08)

본 발명은 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩 복합추출물을 유효성분으로 함유하는 화장료 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a cosmetic composition containing a complex extract of kakadu plum, Indian gooseberry, watercress, asparagus and pea as an active ingredient.

상기 목적을 달성하기 위하여 본 발명에 따르면, 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩 복합추출물을 화장료 조성물 전체 중량에 대하여 0.02 ~ 20 중량% 함유하는 화장료 조성물이 제공된다.According to the present invention in order to achieve the above object, a cosmetic composition containing 0.02 to 20% by weight of kakadu plum, Indian gooseberry, watercress, asparagus and pea complex extract based on the total weight of the cosmetic composition is provided.

상기 복합추출물은 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩이 각각 1~5:1~5:1~5:1~5:1~5의 중량비율로 혼합되어 추출되는 것이며, 더욱 바람직하게는 2:3:4:5:1의 비율로 혼합되어 추출되는 것이다.The composite extract is extracted by mixing kakadu plum, Indian gooseberry, watercress, asparagus and peas in a weight ratio of 1 to 5:1 to 5:1 to 5:1 to 5:1 to 5, respectively, and more preferably Preferably, it is mixed and extracted at a ratio of 2:3:4:5:1.

상기 복합추출물은 물, 탄소수 1~4의 저급 알코올, 글리세린, 에틸렌글리콜, 프로필렌글리콜 및 부틸렌글리콜로 이루어진 군으로부터 선택되는 적어도 하나의 용매로 추출하여 제조되는 것이다.The composite extract is prepared by extraction with at least one solvent selected from the group consisting of water, lower alcohols having 1 to 4 carbon atoms, glycerin, ethylene glycol, propylene glycol and butylene glycol.

상기 화장료 조성물은 피부 재생용, 피부 염증개선용, 피부 자극완화 및 진정용, 피부장벽 강화용인 것을 특징으로 한다.The cosmetic composition is characterized in that it is for skin regeneration, skin inflammation improvement, skin irritation relief and soothing, and skin barrier strengthening.

본 발명의 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩 복합추출물은 인체에 안전하면서도, 그 상승작용에 의하여 우수한 피부 재생효과, 피부 염증개선 효과, 피부 자극 완화 및 진정효과, 피부장벽 강화 효과를 나타내므로 피부 개선용 화장료로 유용하게 사용될 수 있다.The kakadu plum, Indian gooseberry, watercress, asparagus, and pea complex extracts of the present invention are safe to the human body, and have excellent skin regeneration effects, skin inflammation improvement effects, skin irritation relief and soothing effects, and skin barrier strengthening effects due to their synergistic action. It can be usefully used as a cosmetic for skin improvement.

도 1은 본 발명의 실시예에 따라 제조된 복합추출물의 Wound healing효과를 나타내는 그래프이다.
도 2는 본 발명의 실시예에 따라 제조된 복합추출물의 염증매개인자의 발현 억제효과를 나타내는 그래프이다.
도 3은 본 발명의 실시예에 따라 제조된 복합추출물의 장벽관련인자 발현 증가효과를 나타내는 그래프이다.
1 is a graph showing the Wound healing effect of the composite extract prepared according to an embodiment of the present invention.
Figure 2 is a graph showing the expression inhibitory effect of inflammatory mediators of the composite extract prepared according to an embodiment of the present invention.
Figure 3 is a graph showing the effect of increasing the expression of barrier-related factors of the composite extract prepared according to an embodiment of the present invention.

이하 본 발명을 더욱 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail.

카카두플럼(Terminalia Ferdinandiana)은 해충에 강하고 자생능력이 뛰어나며 열매, 잎, 뿌리, 나무 전체를 식품, 의약품, 또는 화장품 원료로 사용한다. 카카두플럼은 지구상의 현존하는 식물 중 비타민 C가 가장 많이 함유돼 있으며, 비타민C는 프롤린과 아미노산의 콜라겐 합성을 촉진시켜 피부탄력 증진에 도움을 주고 활성산소와 자외선으로부터 피부를 보호한다. 본 발명에서는 잎, 줄기, 열매, 전초를 사용할 수 있으며, 바람직하게는 열매를 사용한다.Kakadu plum ( Terminalia Ferdinandiana ) is resistant to pests and has excellent self-sustaining ability, and fruits, leaves, roots, and whole trees are used as food, medicine, or cosmetic raw materials. Kakadu Plum contains the most vitamin C among existing plants on earth. Vitamin C promotes collagen synthesis of proline and amino acids to help improve skin elasticity and protects the skin from active oxygen and UV rays. In the present invention, leaves, stems, fruits, and outposts may be used, and fruits are preferably used.

인디언구스베리(Phyllanthus emblica Linn.)는 일반적으로 '암라'로 불리며 대극과 낙엽교목이다. 인도 전역에 자생하며 재배되기도 하고 성스러운 나무로 간주된다. 인디언구스베리 열매는 비타민 C, 미네랄, 아미노산, 탄닌, 플라보노이드, 엘라그산 등을 함유하여 항산화, 항염증, 피부 보호 활성을 가지고 있다. 본 발명에서는 잎, 줄기, 열매, 전초를 사용할 수 있으며, 바람직하게는 열매를 사용한다.Indian gooseberry ( Phyllanthus emblica Linn. ), commonly called 'Amla', is a dipole and deciduous tree. It grows wild throughout India, is cultivated, and is considered a sacred tree. Indian gooseberry fruit contains vitamin C, minerals, amino acids, tannins, flavonoids, ellagic acid, etc., and has antioxidant, anti-inflammatory, and skin protection activities. In the present invention, leaves, stems, fruits, and outposts may be used, and fruits are preferably used.

물냉이(Nasturtium officinale)는 유럽과 서아시아 북부가 원산지인 겨자과에 속하는 다년생 수생 초본식물로 워터크래스(Watercress) 또는 크레송으로 더 많이 알려져 있다. 물냉이에는 단백질, 칼슘, 철분, 비타민 A, B1, B2, C, E 등이 다량 함유되어 있으며 항산화 효과를 나타내고 잎과 줄기에는 글루코나스투르틴(gluconasturtin)이라는 배당체를 함유하고 있어 가수분해하면 PEITC(phenylethylisothiocyanate)가 생성되는데 이 성분은 DNA 손상 예방에 도움을 준다. 본 발명에서는 잎, 줄기, 뿌리, 전초를 사용할 수 있으며, 바람직하게는 전초를 사용한다. Watercress ( Nasturtium officinale ) is a perennial aquatic herbaceous plant belonging to the mustard family native to Europe and northern western Asia, better known as Watercress or Cressong. Watercress contains a large amount of protein, calcium, iron, vitamins A, B1, B2, C, E, etc., and has an antioxidant effect. Its leaves and stems contain a glycoside called gluconasturtin. (phenylethylisothiocyanate) is produced, which helps prevent DNA damage. In the present invention, leaves, stems, roots, and outposts may be used, and preferably, outposts are used.

아스파라거스는(Asparagus officinalis)는 100-180cm 높이로 자라는 초본 식물 다년생 식물로 원산지가 유럽, 북아프리카, 남아시아인 백합목의 외떡잎식물이다. 아스파라거스는 각종 비타민, 아미노산 등이 풍부하고 특히 아미노산의 일종인 아스파라긴산이 다량 함유되어, 피로회복 및 숙취해소를 돕는 역할을 하는 것으로 알려져 있으며 플라보노이드 계열의 성분 중 루틴의 함량이 높아 항산화 효과를 가지고 있다. 또한 보고된 연구자료에 의하면 아스파라거스는 자외선을 조사한 피부세포 주기 활성화에 효과적인 것으로 보고되었다. 본 발명에서는 뿌리, 줄기, 싹, 전초를 사용할 수 있으며, 바람직하게는 싹을 사용한다. Asparagus ( Asparagus officinalis ) is a herbaceous perennial plant that grows to a height of 100-180 cm, and is a monocotyledonous plant of the lily order, originating from Europe, North Africa, and South Asia. Asparagus is rich in various vitamins and amino acids, and in particular, contains a large amount of aspartic acid, a kind of amino acid, and is known to help recover from fatigue and relieve hangovers. In addition, according to the reported research data, asparagus was reported to be effective in activating the skin cell cycle irradiated with ultraviolet rays. Roots, stems, shoots, and outposts may be used in the present invention, and shoots are preferably used.

완두콩(Pisum Sativum)은 콩과식물에 속하는 한, 두해살이풀이다. 중앙아시아와 중동지역이 원산지이며 고대 그리스 사람들은 기원전 400~500년에 이미 재배해서 먹은 것으로 알려져 있다. 완두콩은 탄수화물과 단백질, 비타민B군이 풍부하여 피부 보호효과를 가지고 있다. 본 발명에서는 잎, 줄기, 낟알을 사용할 수 있으며, 바람직하게는 낟알을 사용한다. Pea ( Pisum Sativum ) is a biennial plant belonging to the legume family. It is native to Central Asia and the Middle East, and it is known that the ancient Greeks cultivated and ate it already in 400-500 BC. Peas are rich in carbohydrates, proteins, and B vitamins, so they have a protective effect on the skin. In the present invention, leaves, stems, and grains may be used, and grains are preferably used.

본 발명의 일 구체예에 따르면 다음과 같은 방법에 의하여 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스, 완두콩으로 이루어진 복합추출물을 제조한다.According to one embodiment of the present invention, a composite extract consisting of kakadu plum, Indian gooseberry, watercress, asparagus, and pea is prepared by the following method.

먼저 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스, 완두콩을 혼합하고, 물, 탄소수 1~4의 저급 알코올, 글리세린, 에틸렌글리콜, 프로필렌글리콜 및 부틸렌글리콜로 이루어진 군으로부터 선택되는 적어도 하나의 용매로 추출 및 여과 후 감압 농축하여 복합추출물을 제조한다. 바람직하게는 물과 부틸렌글리콜의 혼합 용매를 사용하여 추출한다.First, kakadu plum, Indian gooseberry, watercress, asparagus, and peas are mixed, and at least one solvent selected from the group consisting of water, lower alcohol having 1 to 4 carbon atoms, glycerin, ethylene glycol, propylene glycol, and butylene glycol is used. After extraction and filtration, concentrated under reduced pressure to prepare a composite extract. Preferably, extraction is performed using a mixed solvent of water and butylene glycol.

바람직하게는 상기 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩을 각각 1~5:1~5:1~5:1~5:1~5의 중량비율로 혼합하여 추출하며, 2:3:4:5:1의 비율로 혼합하여 추출하는 경우에 가장 우수한 피부 보호효과, 피부 염증개선 효과, 피부 자극 완화 및 진정효과, 피부 장벽 강화 효과를 나타내므로 더욱 바람직하다. 상기 복합추출물은 각각의 추출물을 제조한 후 상기 비율로 혼합하여 제조될 수도 있다.Preferably, the kakadu plum, Indian gooseberry, watercress, asparagus and pea are mixed and extracted in a weight ratio of 1 to 5:1 to 5:1 to 5:1 to 5:1 to 5, respectively, and 2:3 When mixed and extracted at a ratio of 4:5:1, it is more preferable because it shows the best skin protection effect, skin inflammation improvement effect, skin irritation relief and soothing effect, and skin barrier strengthening effect. The composite extract may be prepared by mixing in the above ratio after preparing each extract.

활성성분으로서의 상기 복합 추출물은 화장료 조성물 전체 중량에 대하여 0.02 ~ 20 중량%, 더욱 바람직하게는 0.5 ~ 5.0중량%의 비율로 함유된다.The composite extract as an active ingredient is contained in an amount of 0.02 to 20% by weight, more preferably 0.5 to 5.0% by weight, based on the total weight of the cosmetic composition.

상기 화장료 조성물은 피부 재생용, 피부 염증개선용, 피부 자극완화 및 진정용, 피부장벽 강화용으로 사용될 수 있다.The cosmetic composition may be used for skin regeneration, skin inflammation improvement, skin irritation relief and soothing, and skin barrier strengthening.

본 발명에서 상기 화장료 조성물의 제형은 제한되지는 않으나 일반적인 유화 제형 및 가용화 제형의 형태로 제조할 수 있다. 유화 제형의 화장품으로는 로션, 크림, 로션, 샴푸, 클렌징 폼 등이 있으며, 가용화 제형의 화장품으로는 스킨, 스킨 소프너, 스킨토너, 팩 등이 있다. In the present invention, the formulation of the cosmetic composition is not limited, but may be prepared in the form of a general emulsified formulation and a solubilized formulation. Emulsified cosmetics include lotions, creams, lotions, shampoos, cleansing foams, etc., and solubilized cosmetics include toners, skin softeners, skin toners, packs, and the like.

또한, 화장품 이외에도 피부 과학적으로 허용 가능한 매질 및 기제를 함유함으로써 피부과학 분야에서 통상적으로 사용되는 국소 적용 및 전신 적용할 수 있는 보조제 형태로 제조될 수 있다.In addition, by containing a dermatologically acceptable medium and base other than cosmetics, it can be prepared in the form of an adjuvant that can be applied topically and systemically, which is commonly used in the field of dermatology.

[실시예][Example]

이하, 본 발명의 바람직한 실시예를 통해 본 발명의 구성 및 작용을 더욱 상세히 설명하기로 한다. 다만, 하기 실시예는 본 발명의 이해를 돕기 위한 것으로, 본 발명의 범위가 하기 실시예에 한정되지는 않는다.Hereinafter, the configuration and operation of the present invention will be described in more detail through preferred embodiments of the present invention. However, the following examples are provided to aid understanding of the present invention, and the scope of the present invention is not limited to the following examples.

실시예 1: 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩 복합추출물의 제조Example 1: Preparation of kakadu plum, Indian gooseberry, watercress, asparagus and pea complex extract

세척 건조된 카카두플럼 열매, 인디언구스베리 열매, 물냉이 전초, 아스파라거스 싹, 완두콩 낟알을 각각 1:1:1:1:1의 비율로 혼합(총 중량 500g)한 후 10배의 정제수에 넣고 50℃에서 3 시간 추출한 다음 감압 농축기를 이용하여 65~75℃의 온도에서 농축 한 후 5배의 정제수로 희석하여 복합추출물을 제조하였다.Washed and dried kakadu plum fruit, Indian gooseberry fruit, watercress outpost, asparagus sprout, and pea grain were mixed in a ratio of 1:1:1:1:1 (total weight 500g), and then added to 10 times purified water and 50 After extracting for 3 hours at ℃ and then concentrating at a temperature of 65 ~ 75 ℃ using a vacuum concentrator, it was diluted with 5 times purified water to prepare a composite extract.

실시예 2: 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스, 완두콩 복합추출물의 제조Example 2: Preparation of kakadu plum, Indian gooseberry, watercress, asparagus, pea composite extract

카카두플럼, 인디언구스베리, 물냉이, 아스파라거스, 완두콩의 중량비를 하기 표 1과 같이 조절(총 중량 500g)하여 상기 실시예 1과 동일한 방법으로 복합추출물을 제조하였다.A composite extract was prepared in the same manner as in Example 1 by adjusting the weight ratio of kakadu plum, Indian gooseberry, watercress, asparagus, and pea as shown in Table 1 below (total weight: 500 g).

카카두플럼kakadu plum 인디언구스베리Indian gooseberry 물냉이watercress 아스파라거스asparagus 완두콩pea 실시예 2Example 2 1One 22 33 44 55 실시예 3Example 3 22 33 44 55 1One 실시예 4Example 4 33 44 55 1One 22 실시예 5Example 5 44 55 1One 22 33 실시예 6Example 6 55 1One 22 33 44

비교예 1: 카카두플럼 추출물의 제조Comparative Example 1: Preparation of kakadu plum extract

세척 건조된 카카두플럼 500g을 상기 실시예 1의 방법과 동일한 방법으로 추출하여 추출물을 제조하였다.An extract was prepared by extracting 500 g of the washed and dried kakadu plum in the same manner as in Example 1.

비교예 2: 인디언구스베리 추출물의 제조Comparative Example 2: Preparation of Indian gooseberry extract

세척 건조된 인디언구스베리 500g을 상기 실시예 1의 방법과 동일한 방법으로 추출하여 추출물을 제조하였다. An extract was prepared by extracting 500 g of the washed and dried Indian gooseberry in the same manner as in Example 1.

비교예 3: 물냉이 추출물의 제조Comparative Example 3: Preparation of watercress extract

세척 건조된 물냉이 500g을 상기 실시예 1의 방법과 동일한 방법으로 추출하여 추출물을 제조하였다.An extract was prepared by extracting 500 g of washed and dried watercress in the same manner as in Example 1.

비교예 4: 아스파라거스 추출물의 제조Comparative Example 4: Preparation of Asparagus Extract

세척 건조된 아스파라거스 500g을 상기 실시예 1의 방법과 동일한 방법으로 추출하여 추출물을 제조하였다.An extract was prepared by extracting 500 g of the washed and dried asparagus in the same manner as in Example 1.

비교예 5: 완두콩 추출물의 제조Comparative Example 5: Preparation of pea extract

세척 건조된 완두콩 500g을 상기 실시예 1의 방법과 동일한 방법으로 추출하여 추출물을 제조하였다. An extract was prepared by extracting 500 g of washed and dried peas in the same manner as in Example 1.

시험예 1: 세포 무독성 및 세포증식 효과 확인Test Example 1: Confirmation of cell non-toxicity and cell proliferation effect

상기 실시예 및 비교예에서 제조된 추출물을 사용하여 세포 독성 및 증식 효과를 확인하였다. 각질형성세포 HaCaT을 96-웰 마이크로 플레이트의 각 웰에 1×104 세포가 되도록 접종하고, DMEM 배지를 이용해 37℃에서 24시간 동안 배양하였다. 이어, 실시예 및 비교예의 최종 농도를 각각 0.5, 1.0%, 2.0%, 5.0%로 하여 혈청이 2.5% 함유되어 있는 DMEM 배지로 교체한 실험군과 혈청이 없는 DMEM 배지로 교체한 대조군을 24시간 동안 추가로 배양하였다. 배양 후, 세포의 생존율을 비교하기 위하여 MTT 솔루션(3mg/ml)을 첨가하여 세포 생존율을 ELISA READER를 이용하여 570nm에서 흡광도를 측정하였으며, 대조군 대비 시료 투입 실험군의 세포 증식률을 계산하였다.The cytotoxic and proliferative effects were confirmed using the extracts prepared in the above Examples and Comparative Examples. HaCaT keratinocytes were inoculated into each well of a 96-well microplate to form 1×10 4 cells, and cultured at 37° C. for 24 hours using DMEM medium. Then, the final concentrations of Examples and Comparative Examples were 0.5, 1.0%, 2.0%, and 5.0%, respectively, and the experimental group replaced with DMEM medium containing 2.5% serum and the control group replaced with serum-free DMEM medium for 24 hours. further cultured. After culturing, in order to compare the viability of the cells, MTT solution (3mg / ml) was added, and the cell viability was measured by using an ELISA READER to measure the absorbance at 570 nm, and the cell proliferation rate of the experimental group compared to the control group was calculated.

세포 증식률(%)Cell proliferation rate (%) 구분/농도Classification/Concentration 0%(대조군)0% (control) 0.5%0.5% 1.0%1.0% 2.0%2.0% 5.0%5.0% 실시예 1Example 1 100100 93.493.4 92.792.7 88.588.5 87.287.2 실시예 2Example 2 100100 103.7103.7 102.4102.4 100.1100.1 100.2100.2 실시예 3Example 3 100100 107.7107.7 107.8107.8 105.8105.8 105.3105.3 실시예 4Example 4 100100 103.4103.4 101.3101.3 100.4100.4 99.599.5 실시예 5Example 5 100100 98.798.7 97.897.8 94.594.5 92.592.5 실시예 6Example 6 100100 100.1100.1 98.498.4 95.395.3 92.292.2 비교예 1Comparative Example 1 100100 94.494.4 90.590.5 89.789.7 88.488.4 비교예 2Comparative Example 2 100100 94.894.8 92.492.4 88.288.2 87.787.7 비교예 3Comparative Example 3 100100 98.898.8 95.595.5 93.493.4 92.492.4 비교예 4Comparative Example 4 100100 104.4104.4 102.2102.2 102.3102.3 99.899.8 비교예 5Comparative Example 5 100100 97.797.7 97.197.1 96.696.6 95.595.5

상기 표 2에서 나타난 바와 같이, 세포 성장 최적 조건에서의 세포 증식을 100%로 하였을 때, 실시예 및 비교예 추출물들은 모두 세포 무독성이며, 실시예 2 내지 4, 실시예 6과 비교예 4에서 세포 증식 효과가 우수한 것으로 확인되었다.As shown in Table 2, when the cell proliferation in the cell growth optimal conditions is 100%, the extracts of Examples and Comparative Examples are all non-toxic to cells, and in Examples 2 to 4, Example 6 and Comparative Example 4, cell It was confirmed that the proliferative effect was excellent.

시험예 2: 피부자극 안전성 평가Test Example 2: Skin irritation safety evaluation

상기 실시예 및 비교예에서 제조된 추출물의 피부안전성을 평가하기 위해 건강한 10~30대 피험자 15명을 대상으로 CTFA 가이드라인(The Cosmetic Toiletry and Fragrance association, Safety testing guidelines)에 따라 인체의 피부 첩포시험을 실시하였다. In order to evaluate the skin safety of the extracts prepared in the above Examples and Comparative Examples, 15 healthy subjects in their 10s to 30s were tested according to CTFA guidelines (The Cosmetic Toiletry and Fragrance association, Safety testing guidelines). was carried out.

실시예 및 비교예의 추출물을 Finn chambers on Scanpor tape를 이용하여 20uL씩 24시간 도포하였다. 첩포를 제거한 후는 30분, 24시간, 48시간 후에 각 시험 부위의 피부자극반응을 관찰하여 국제 접촉 피부염 연구회(International Contact Dermatitis Research Group; ICDRG)의 규정에 따라 판정하도록 하였다. 국제 접촉 피부염 연구회의 피부 안전성 판독의 판정기준을 표 3에 기재하였으며, 평가 기준에 따른 평균 결과 값을 표 4에 나타내었다.The extracts of Examples and Comparative Examples were applied for 24 hours at 20uL each using Finn chambers on Scanpor tape. After removing the patch, the skin irritation reaction of each test site was observed 30 minutes, 24 hours, and 48 hours later, and judged according to the regulations of the International Contact Dermatitis Research Group (ICDRG). The criteria for skin safety reading of the International Contact Dermatitis Study Society are listed in Table 3, and the average result values according to the evaluation criteria are shown in Table 4.

SymbolSymbol Clinical DescriptionClinical Description -- 무자극non-irritating ±± 미자극, 희미한 또는 가까스로 감지할 수 있는 옅은 홍반Unirritable, faint or barely perceptible pale erythema ++ 경자극, 경계가 뚜렷하거나 약한 홍반, 부종 및 구진Mild irritation, well-bordered erythema, edema, and papules ++++ 중자극, 뚜렷한 홍반, 구진 및 소수포Moderate irritation, marked erythema, papules and vesicles ++++++ 강자극, 심한 홍반 및 대수포, 가피형성Severe irritation, severe erythema and blisters, scab formation -- ±± ++ ++++ ++++++ ScoreScore 0.00.0 0.50.5 1.01.0 2.02.0 3.03.0

구분division 30분 후30 minutes later 24시간 후24 hours later 48시간 후48 hours later 판정Judgment 실시예 1Example 1 0.00.0 0.00.0 0.00.0 무자극non-irritating 실시예 2Example 2 0.00.0 0.00.0 0.00.0 무자극non-irritating 실시예 3Example 3 0.00.0 0.00.0 0.00.0 무자극non-irritating 실시예 4Example 4 0.00.0 0.00.0 0.00.0 무자극non-irritating 실시예 5Example 5 0.00.0 0.00.0 0.00.0 무자극non-irritating 실시예 6Example 6 0.00.0 0.00.0 0.00.0 무자극non-irritating 비교예 1Comparative Example 1 0.50.5 0.50.5 0.00.0 미자극unstimulated 비교예 2Comparative Example 2 0.50.5 0.50.5 0.00.0 미자극unstimulated 비교예 3Comparative Example 3 0.00.0 0.00.0 0.00.0 무자극non-irritating 비교예 4Comparative Example 4 0.00.0 0.00.0 0.00.0 무자극non-irritating 비교예 5Comparative Example 5 0.50.5 0.00.0 0.00.0 미자극unstimulated

상기 표 4에서 확인되는 바와 같이, 실시예의 추출물들은 피부에 자극이 없는 것으로 나타났으며, 비교예 1, 비교예 2, 비교예 5의 경우 약간의 자극을 나타내었다.As confirmed in Table 4, the extracts of Examples showed no irritation to the skin, and Comparative Example 1, Comparative Example 2, and Comparative Example 5 showed slight irritation.

시험예 3: Wound healing 효과 확인 Test Example 3: Confirmation of wound healing effect

상기 실시예 및 비교예에서 제조된 추출물의 피부 재생효과를 확인하기 위하여 Wound healing assay를 실시하였다. HaCaT 세포를 6 well plate에 1×106cells/well의 농도로 분주하여 배양한 후, FBS가 첨가되지 않은 배지로 교체하여 18시간 starvation 시키고, 24시간 동안 배양한 다음 scratch한 뒤 대조군은 FBS가 포함된 배지를 이용하였으며 HaCaT 세포에 2% 시료 처리하고, 24시간 배양한 후 전자현미경 100 배율로 관찰하였다. 세포재생율은 아래의 식에 의하여 계산하였으며, 그 결과를 도 1에 나타내었다.In order to confirm the skin regeneration effect of the extracts prepared in the above Examples and Comparative Examples Wound healing assay was performed. HaCaT cells were divided and cultured in a 6-well plate at a concentration of 1×10 6 cells/well, replaced with FBS-free medium, starvated for 18 hours, cultured for 24 hours, scratched, and the control was FBS-free. The included medium was used, and HaCaT cells were treated with 2% sample, cultured for 24 hours, and observed under an electron microscope at 100 magnification. The cell regeneration rate was calculated by the formula below, and the results are shown in FIG. 1 .

세포재생율(%)= [(시료처리 후 plate 면적/scratch 직후 plate 면적)×100]Cell regeneration rate (%) = [(plate area after sample treatment / plate area immediately after scratch) × 100]

Wound healing 효과를 측정한 결과, 상기 실시예와 비교예에 따라 제조된 추출물에서 세포 간 간격이 좁아짐을 확인하였으며, 상기 실시예의 복합추출물에서 비교예의 각각의 추출물들에 비하여 더욱 우수한 wound healing 효과를 나타냄을 알 수 있었다. 그 중에서도 실시예 2와 3의 복합추출물에서 더욱 우수한 세포 재생율을 나타내어 피부 재생효과가 우수함을 알 수 있었다.As a result of measuring the wound healing effect, it was confirmed that the interval between cells was narrowed in the extracts prepared according to the above examples and comparative examples, and the composite extracts of the above examples showed a more excellent wound healing effect than each extract of the comparative examples And it was found. Among them, it was found that the composite extracts of Examples 2 and 3 exhibited a more excellent cell regeneration rate, indicating that the skin regeneration effect was excellent.

시험예 4: 염증매개인자 발현량 측정Test Example 4: Measurement of expression level of inflammatory mediators

상기 실시예 및 비교예에서 제조된 추출물을 사용하여 염증매개인자인 종양괴사인자(TNF-α)와 핵전사인자로서 세포의 생존과 자극에 대한 세포 반응에 관여하는 NF-kB 발현 억제효과를 확인하였다.Using the extracts prepared in the above Examples and Comparative Examples, tumor necrosis factor (TNF-α), an inflammatory mediator, and NF-kB expression inhibitory effect, which is involved in cell survival and cell response to stimulation as a nuclear transcription factor, were confirmed. did

HaCaT 세포를 12 well plate에 1×106cells/well의 농도로 분주하여 24 시간 동안 배양하였다. HaCaT 세포에 LPS 10ng/mL씩 처리하고, 24시간 배양한 후 배양된 세포에서 RNA를 추출하여 Reverse transcription polymerase chain reaction(RT-PCR)을 통해 TNF-α와 NF-kB의 발현량을 측정하여 그 결과를 도 2에 나타내었다. 염증매개인자 발현억제율은 하기 식에 의해 산출하였고, 음성대조군으로는 무처리군, 양성대조군으로는 덱사메타손(Dexamethason) 100μM을 사용하였다.HaCaT cells were dispensed in a 12 well plate at a concentration of 1×10 6 cells/well and cultured for 24 hours. HaCaT cells were treated with 10 ng/mL of LPS, incubated for 24 hours, RNA was extracted from the cultured cells, and the expression levels of TNF-α and NF-kB were measured through reverse transcription polymerase chain reaction (RT-PCR). Results are shown in FIG. 2 . The rate of inhibition of expression of inflammatory mediators was calculated by the following formula, and an untreated group was used as a negative control group, and 100 μM of dexamethasone was used as a positive control group.

염증매개인자 발현억제율(%)=100-[(시료의 발현양/음성대조군의 발현양) ×100]Inhibition rate of inflammatory mediator expression (%) = 100 - [(expression amount of sample / expression amount of negative control group) × 100]

도 2에서 확인되는 바와 같이 상기 실시예의 복합추출물에서 비교예의 각각의 추출물들에 비하여 더욱 우수한 염증매개인자 발현억제 효과를 나타내었다. 그 중에서도 실시예 3의 복합추출물에서 가장 우수한 효과를 나타내었다.As shown in Figure 2, the composite extract of Example exhibited a more excellent inhibitory effect on the expression of inflammatory mediators than each of the extracts of Comparative Example. Among them, the composite extract of Example 3 showed the most excellent effect.

시험예 5: 피부장벽관련인자 발현 증가효과 확인Test Example 5: Confirmation of skin barrier-related factor expression increase effect

상기 실시예 및 비교예에서 제조된 추출물을 사용하여 포유류 표피세포의 케라틴결합단백질인 FLG(Filaggrin)과 단백질 가교결합에 관여하는 TGM 1(transglutaminase 1)의 발현량을 측정하여 장벽관련인자의 발현 증가효과를 확인하였다.Using the extracts prepared in the above Examples and Comparative Examples, the expression level of TGM 1 (transglutaminase 1) involved in protein cross-linking with FLG (Filaggrin), a keratin-binding protein of mammalian epidermal cells, was measured to increase the expression of barrier-related factors. The effect was confirmed.

HaCaT 세포를 12 well plate에 1×106cells/well의 농도로 분주하여 24 시간 동안 배양하였다. HaCaT 세포에 UVB 200mJ/cm2씩 처리하고, 24시간 배양한 후 배양된 세포에서 RNA를 추출하여 Reverse transcription polymerase chain reaction(RT-PCR)을 통해 FLG과 TGM 1의 발현량을 측정하고 그 결과를 도 3에 나타내었다. 장벽관련인자 발현증가율은 하기 식에 의해 산출하였고, 음성대조군으로는 무처리군, 양성대조군으로는 Retinoic Acid 50ppm을 사용하였다.HaCaT cells were dispensed in a 12 well plate at a concentration of 1×10 6 cells/well and cultured for 24 hours. HaCaT cells were treated with UVB of 200mJ/cm 2 , incubated for 24 hours, RNA was extracted from the cultured cells, and the expression levels of FLG and TGM 1 were measured through reverse transcription polymerase chain reaction (RT-PCR), and the results were analyzed. shown in Figure 3. The rate of increase in expression of barrier-related factors was calculated by the following formula, and 50 ppm of retinoic acid was used as a negative control group and an untreated group as a positive control group.

장벽관련인자 발현증가율(%)=[(시료의 발현양/음성 대조군의 발현양)×100]Barrier-related factor expression increase rate (%) = [(expression amount of sample / expression amount of negative control group) × 100]

도 3에서 확인되는 바와 같이 상기 실시예 및 비교예의 추출물에서 전반적으로 높은 피부장벽관련 인자의 발현증가율을 나타내었으며, 그 중에서도 실시예 2와 3에서 더욱 우수한 효과를 나타내었다.As confirmed in Figure 3, the extracts of Examples and Comparative Examples showed a high expression increase rate of skin barrier-related factors overall, and among them, Examples 2 and 3 showed more excellent effects.

제형 실시예 1~4: 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩 복합추출물을 함유하는 로션 제조Formulation Examples 1 to 4: Preparation of lotion containing complex extracts of kakadu plum, Indian gooseberry, watercress, asparagus and pea

하기 표 5의 조성에 따라 통상의 방법으로 상기 실시예 및 비교예의 추출물을 유효성분으로 함유하는 로션을 제조하였다.Lotions containing the extracts of Examples and Comparative Examples as active ingredients were prepared in a conventional manner according to the composition shown in Table 5 below.

성 분ingredient 함량(중량%)Content (% by weight) 제형 실시예Formulation Examples 비교예comparative example 1One 22 33 44 66 77 88 99 실시예 2Example 2 0.50.5 5.05.0 -- -- -- -- -- -- 실시예 3Example 3 -- -- 0.50.5 5.05.0 -- -- -- -- 비교예 3Comparative Example 3 -- -- -- -- 0.50.5 5.05.0 -- -- 비교예 4Comparative Example 4 -- -- -- -- -- -- 0.50.5 5.05.0 글리세릴스테아레이트Glyceryl Stearate 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 세토스테아릴알콜Cetostearyl Alcohol 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 스테아린산stearic acid 1.51.5 1.51.5 1.51.5 1.51.5 1.51.5 1.51.5 1.51.5 1.51.5 시어버터shea butter 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 솔비탄스테아레이트Sorbitan Stearate 0.60.6 0.60.6 0.60.6 0.60.6 0.60.6 0.60.6 0.60.6 0.60.6 식물성 스쿠알란vegetable squalane 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 디메치콘dimethicone 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 글리세린glycerin 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 베타인betaine 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 1,2-헥산디올1,2-hexanediol 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 소듐히아루로네이트sodium hyaluronate 4.04.0 4.04.0 4.04.0 4.04.0 4.04.0 4.04.0 4.04.0 4.04.0 방부제, 향, 색소preservatives, fragrances, colors 미량a very small amount 미량a very small amount 미량a very small amount 미량a very small amount 미량a very small amount 미량a very small amount 미량a very small amount 미량a very small amount 정제수Purified water 잔량balance 잔량balance 잔량balance 잔량balance 잔량balance 잔량balance 잔량balance 잔량balance

시험예 6: 피부 홍반완화 효과 측정Test Example 6: Measurement of skin erythema alleviation effect

상기 제형 실시예 및 비교예에서 제조된 로션을 사용하여 자극으로 인한 붉은 피부를 가진 여성 40명을 선정하여 각각 5명씩 그룹으로 나누어 1일 2회씩 2주간 안면부에 사용하도록 하게 한 후의 홍반지수를 측정하였다. 측정 방법은 Mexameter MX 18(Courage+Khazaka Electronic, Germany)을 이용하여 양 볼 부위에 Mexameter MX 18을 접촉한 후 1초 이내에 센서를 통하여 홍반지수(eryhma Index, EI)를 측정하였다. 개인당 3번 반복 측정하였다. 그 평균값은 하기 표 6에 나타내었다.Using the lotion prepared in Formulation Examples and Comparative Examples, 40 women with red skin due to irritation were selected, divided into groups of 5 each, and used on the face twice a day for 2 weeks. Measure the erythema index after having them used. did For the measurement method, Mexameter MX 18 (Courage + Khazaka Electronic, Germany) was used to measure the eryhma index (EI) through the sensor within 1 second after contacting Mexameter MX 18 on both cheeks. Measurements were repeated 3 times per individual. The average values are shown in Table 6 below.

시료명sample name 사용 전 홍반지수(EI)Erythema Index (EI) before use 사용 후 홍반지수(EI)Post-use erythema index (EI) 제형 실시예 1Formulation Example 1 13.2±7.213.2±7.2 9.5±3.39.5±3.3 제형 실시예 2Formulation Example 2 15.2±3.215.2±3.2 5.1±3.85.1±3.8 제형 실시예 3Formulation Example 3 14.2±8.814.2±8.8 8.8±2.58.8±2.5 제형 실시예 4Formulation Example 4 14.8±4.114.8±4.1 4.2±1.24.2±1.2 비교예 6Comparative Example 6 15.4±5.515.4±5.5 11.2±3.811.2±3.8 비교예 7Comparative Example 7 13.5±3.813.5±3.8 5.5±2.45.5±2.4 비교예 8Comparative Example 8 13.9±5.313.9±5.3 10.1±3.610.1±3.6 비교예 9Comparative Example 9 14.7±6.214.7±6.2 5.8±4.25.8±4.2

표 6에서 확인되는 바와 같이, 본 발명 실시예의 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩 복합추출물을 함유하는 로션은 홍반완화 효과를 나타내었고, 고농도에서 홍반완화 효과가 더 우수함을 확인 할 수 있었다. 그 중에서도 실시예 3의 복합추출물을 5% 함유한 제형 실시예 4 로션이 가장 우수한 홍반 완화 효과를 나타내었다.As confirmed in Table 6, the lotion containing the kakadu plum, Indian gooseberry, watercress, asparagus and pea complex extracts of the present invention showed an erythema alleviation effect, and it can be confirmed that the erythema alleviation effect is better at high concentrations. could Among them, the formulation Example 4 lotion containing 5% of the complex extract of Example 3 exhibited the most excellent erythema alleviation effect.

시험예 7: 피부장벽개선 평가Test Example 7: Skin barrier improvement evaluation

피부장벽개선 정도를 평가하기 위하여 경표피의 수분 손실량을 평가하였다. 상기 제형 실시예 및 비교예에서 제조된 로션을 사용하여 여성 40명을 대상으로 각각 5명씩 그룹으로 나누어 1일 2회씩 2주간 안면부에 사용하도록 하게 한 후의 경피수분손실량을 측정하였다. 측정 방법은 Dermalab combo(Cortex technology, Denmark)를 이용하여 양 볼 부위에 TEWL probe을 접촉한 후 경피수분손실량을(g/m2/h) 측정하였다. 개인당 3번 반복 측정하였다. 그 평균값은 하기 표 7에 나타내었다.In order to evaluate the degree of skin barrier improvement, the amount of water loss in the transepidermal layer was evaluated. Using the lotions prepared in Formulation Examples and Comparative Examples, 40 women were divided into groups of 5 each and used on the face twice a day for 2 weeks, and then the amount of transepidermal water loss was measured. The measurement method was to measure the transepidermal water loss (g/m 2 /h) after contacting the TEWL probe to both cheeks using Dermalab combo (Cortex technology, Denmark). Measurements were repeated 3 times per individual. The average values are shown in Table 7 below.

시료명sample name 사용 전 경피수분손실량(g/m2/h)Transepidermal water loss before use (g/m 2 /h) 사용 후 경피수분손실량(g/m2/h)Transepidermal water loss after use (g/m 2 /h) 제형 실시예 1Formulation Example 1 17.717.7 7.17.1 제형 실시예 2Formulation Example 2 15.515.5 4.24.2 제형 실시예 3Formulation Example 3 16.516.5 6.56.5 제형 실시예 4Formulation Example 4 16.416.4 3.83.8 비교예 6Comparative Example 6 15.815.8 9.89.8 비교예 7Comparative Example 7 16.716.7 8.18.1 비교예 8Comparative Example 8 17.717.7 11.211.2 비교예 9Comparative Example 9 16.516.5 7.87.8

표 7에서 확인되는 바와 같이, 본 발명 실시예의 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩 복합추출물을 함유하는 로션은 경피수분손실량 감소 효과를 나타내었고, 고농도에서 경피수분손실량 감소 효과가 더 우수함을 확인할 수 있었다. 그 중에서도 실시예 3의 복합추출물을 5% 함유한 제형 실시예 4 로션이 가장 우수한 경피수분손실량 감소 효과를 나타내었다.As confirmed in Table 7, the lotion containing the kakadu plum, Indian gooseberry, watercress, asparagus, and pea complex extracts of the examples of the present invention showed an effect of reducing transepidermal water loss, and at high concentrations, the effect of reducing transepidermal water loss was more excellence was confirmed. Among them, the formulation Example 4 lotion containing 5% of the complex extract of Example 3 exhibited the most excellent transepidermal water loss reduction effect.

Claims (7)

카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩 복합추출물을 화장료 조성물 전체 중량에 대하여 0.02 ~ 20 중량% 함유하는 화장료 조성물.A cosmetic composition containing 0.02 to 20% by weight of a complex extract of kakadu plum, Indian gooseberry, watercress, asparagus and pea, based on the total weight of the cosmetic composition. 제1항에 있어서, 상기 복합추출물은 카카두플럼, 인디언구스베리, 물냉이, 아스파라거스 및 완두콩이 각각 1~5:1~5:1~5:1~5:1~5의 중량비율로 혼합되어 추출되는 것임을 특징으로 하는 화장료 조성물. According to claim 1, wherein the composite extract is kakadu plum, Indian gooseberry, watercress, asparagus and peas are mixed in a weight ratio of 1 to 5: 1 to 5: 1 to 5: 1 to 5: 1 to 5, respectively A cosmetic composition, characterized in that extracted. 제1항에 있어서, 상기 복합추출물은 물, 탄소수 1~4의 저급 알코올, 글리세린, 에틸렌글리콜, 프로필렌글리콜 및 부틸렌글리콜로 이루어진 군으로부터 선택되는 적어도 하나의 용매로 추출하여 제조되는 것임을 특징으로 하는 화장료 조성물.The method of claim 1, wherein the composite extract is prepared by extracting with at least one solvent selected from the group consisting of water, lower alcohols having 1 to 4 carbon atoms, glycerin, ethylene glycol, propylene glycol and butylene glycol. cosmetic composition. 제1항에 있어서, 상기 화장료 조성물은 피부 재생용임을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the cosmetic composition is for skin regeneration. 제1항에 있어서, 상기 화장료 조성물은 피부 염증개선용임을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the cosmetic composition is for improving skin inflammation. 제1항에 있어서, 상기 화장료 조성물은 피부 자극완화 및 진정용임을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, characterized in that the cosmetic composition is for skin irritation relief and soothing. 제1항에 있어서, 상기 화장료 조성물은 피부장벽 강화용임을 특징으로 하는 화장료 조성물.















The cosmetic composition according to claim 1, wherein the cosmetic composition is for strengthening the skin barrier.















KR1020210064099A 2021-05-18 2021-05-18 Cosmetic composition comprising natural herb complex extract as effective component KR102525630B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210064099A KR102525630B1 (en) 2021-05-18 2021-05-18 Cosmetic composition comprising natural herb complex extract as effective component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210064099A KR102525630B1 (en) 2021-05-18 2021-05-18 Cosmetic composition comprising natural herb complex extract as effective component

Publications (2)

Publication Number Publication Date
KR20220156274A true KR20220156274A (en) 2022-11-25
KR102525630B1 KR102525630B1 (en) 2023-04-26

Family

ID=84237249

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210064099A KR102525630B1 (en) 2021-05-18 2021-05-18 Cosmetic composition comprising natural herb complex extract as effective component

Country Status (1)

Country Link
KR (1) KR102525630B1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150007464A (en) * 2013-07-11 2015-01-21 주식회사 바이오에프디엔씨 Anti-aging and Anti-inflammatory and Anti-oxidant Cosmetic Composition including Beans Placenta Cell Cultures Extracts
KR20150104754A (en) * 2014-03-06 2015-09-16 주식회사 바이오에프디엔씨 Anti-aging and Enhancing Skin Barrier Function composition for skin external application comprising Asparagales Placenta Cell Culture Extract
KR20180013422A (en) 2016-07-29 2018-02-07 주식회사 티젠 농업회사법인 Composition comprising Amla extract for preventing lose of hair or promoting of hair
KR101829553B1 (en) 2016-10-31 2018-02-19 에스케이바이오랜드 주식회사 Cosmetic composition comprising mixture extract of Pisum sativum, Scutellaria baicalensis, Ulmus davidiana, Hippophae rhamnoides fruit for improvement of skin damage or skin-protection
KR20180082177A (en) 2017-01-10 2018-07-18 주식회사 아미코스메틱 Cosmetic composition comprising saccharomyces ferment filtrate, asparagus officinalis stem extract and tussilago farfara flower extract
KR101965250B1 (en) 2018-07-11 2019-04-03 이종현 Cosmetic composition for anti-oxidation, anti-inflammatory and anti-wrinkling containing enzyme-treated extracts of kakadu plum and manufacturing method of extract
KR102062010B1 (en) 2019-08-13 2020-01-02 (주)클래시스 Extract of nasturtium officinale obtained using focused ultrasonic treatment and cosmetic composition for skin regeneration, wrinkle improvement and antioxidative activity comprising the extract

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150007464A (en) * 2013-07-11 2015-01-21 주식회사 바이오에프디엔씨 Anti-aging and Anti-inflammatory and Anti-oxidant Cosmetic Composition including Beans Placenta Cell Cultures Extracts
KR20150104754A (en) * 2014-03-06 2015-09-16 주식회사 바이오에프디엔씨 Anti-aging and Enhancing Skin Barrier Function composition for skin external application comprising Asparagales Placenta Cell Culture Extract
KR20180013422A (en) 2016-07-29 2018-02-07 주식회사 티젠 농업회사법인 Composition comprising Amla extract for preventing lose of hair or promoting of hair
KR101829553B1 (en) 2016-10-31 2018-02-19 에스케이바이오랜드 주식회사 Cosmetic composition comprising mixture extract of Pisum sativum, Scutellaria baicalensis, Ulmus davidiana, Hippophae rhamnoides fruit for improvement of skin damage or skin-protection
KR20180082177A (en) 2017-01-10 2018-07-18 주식회사 아미코스메틱 Cosmetic composition comprising saccharomyces ferment filtrate, asparagus officinalis stem extract and tussilago farfara flower extract
KR101965250B1 (en) 2018-07-11 2019-04-03 이종현 Cosmetic composition for anti-oxidation, anti-inflammatory and anti-wrinkling containing enzyme-treated extracts of kakadu plum and manufacturing method of extract
KR102062010B1 (en) 2019-08-13 2020-01-02 (주)클래시스 Extract of nasturtium officinale obtained using focused ultrasonic treatment and cosmetic composition for skin regeneration, wrinkle improvement and antioxidative activity comprising the extract

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
비특허문헌 *

Also Published As

Publication number Publication date
KR102525630B1 (en) 2023-04-26

Similar Documents

Publication Publication Date Title
KR20090081178A (en) Cosmetic composition containing wild flower extracts
KR101869096B1 (en) Cosmetic compostion for skin moisturizing and anti-wrinkle
KR101319997B1 (en) Cosmetic composition containing extract of Epilobium angustifolium Linne and Adina rubella Hance for improving skin wrinkle
KR101853743B1 (en) External composition for skin containing Kalopanax pictus (Thunb.) Nakai extract
KR20100130878A (en) Cosmetic composition comprising plant extracts
KR100753186B1 (en) A anti-aging cosmetic composition containing a herb extracts mixture
KR101078888B1 (en) A cosmetic composition comprising tissue cultured Echinaceae adventitious roots and an preparing method thereof
KR101397160B1 (en) Cosmetic compositon for skin-irritation alleviation with Inula britannica var. chinensis, Cynanchi Radix and Lysimachia foenum-graecum Hance
KR100984163B1 (en) Humectant cosmetic composition comprising chayote extract and manufacturing method thereof
KR101987421B1 (en) Cosmetic composition for improving antioxidation and skin wrinkle comprising bertholletia excelsa seed oil, plukenetia volubilis seed oil, mangifera indica extract and fragaria chiloensis extract
KR101874605B1 (en) Skin external composition containing Calanthe discolor Lindl. extract
KR100882744B1 (en) Manufacturing method of cometic compositions containing extract of paeonia suffruticosa andrew
KR101110301B1 (en) Whitening cosmetics composition containing the sorbaria sorbifolia var. stellipila extract
KR102213723B1 (en) Cosmetic composition for improving anti-wrinkle containing the extract mori radicis cortex, Lindera obtusiloba and Lespedeza cuneata
KR102525630B1 (en) Cosmetic composition comprising natural herb complex extract as effective component
KR20110089793A (en) A cosmetic composition
KR20200009195A (en) A cosmetic composition comprising ligustrum lucidum extract
KR101574248B1 (en) Cosmetic composition comprising Reynoutria sachalinensis extracts for skin anti-wrinkle effect
KR101214344B1 (en) Cosmetics composition containing fermented rice bran and licorice extract
KR102014842B1 (en) Cosmetic composition containing natural extract
KR20130046994A (en) External composition for skin containing extract of potentilla stolonifera var. quelpaertensis nakai
KR20170058546A (en) Cosmetic Composition for Reducing Skin Wrinkle
KR20080098925A (en) Cometic compositions containing extract of paeonia suffruticosa andrew
KR101081585B1 (en) Cosmetic composition containing extract of ligustrum japonicum and hemerocallis fulva for improving skin wrinkle
KR102550653B1 (en) Cosmetic composition for anti oxidant and cell protection containing mushroom complex

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right